NDC 10135-739

Tranylcypromine

Tranylcypromine

Tranylcypromine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is Tranylcypromine Sulfate.

Product ID10135-739_df892a6f-3d0f-ea21-e053-2a95a90a9ece
NDC10135-739
Product TypeHuman Prescription Drug
Proprietary NameTranylcypromine
Generic NameTranylcypromine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-05-01
Marketing CategoryANDA /
Application NumberANDA206856
Labeler NameMarlex Pharmaceuticals, Inc.
Substance NameTRANYLCYPROMINE SULFATE
Active Ingredient Strength10 mg/1
Pharm ClassesMonoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 10135-739-01

100 TABLET in 1 BOTTLE (10135-739-01)
Marketing Start Date2022-05-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tranylcypromine" or generic name "Tranylcypromine"

NDCBrand NameGeneric Name
0527-3010TranylcypromineTRANYLCYPROMINE
10135-739TranylcypromineTranylcypromine
43547-655TranylcypromineTRANYLCYPROMINE
70954-538TranylcypromineTranylcypromine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.